| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.0M | — |
| R&D Expense | $85.7M | +68.0% |
| SG&A Expense | $26.5M | +31.7% |
| Operating Income | -$111.4M | -56.6% |
| Interest Expense | $1.6M | +30.8% |
| Income Tax | $0 | — |
| Net Income | -$101.9M | -49.3% |
| EPS (Basic) | -$1.40 | -38.6% |
| EPS (Diluted) | -$1.40 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.5M | -12.3% |
| Short-term Investments | $165.9M | -29.7% |
| Current Assets | $206.9M | -27.6% |
| Total Assets | $221.2M | -26.1% |
| Current Liabilities | $17.7M | +61.4% |
| Long-term Debt | $10.0M | +0.0% |
| Total Liabilities | $33.7M | +13.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.6M | -38.7% |
| Capital Expenditures | $1.8M | +14.7% |
| Investing Cash Flow | $76.0M | +183.2% |
| Financing Cash Flow | $638K | -99.5% |
| Free Cash Flow | -$83.5M | -38.1% |
| -38.6% |
| Stockholders' Equity |
| $187.6M |
| -30.5% |